LOS ANGELES, March 9, 2023 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming March 13, 2023deadline to file a lead plaintiff motion in the class action filed on behalf of Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ: BVS) investors who purchased: (a) Class A common stock pursuant and or traceable to the Offering Documents issued in connection with the Company's February 2021 initial public offering ("IPO"); and/or (b) securities between February 11, 2021 and November 21, 2022, inclusive (the "Class Period").
Read more at prnewswire.comProvided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.